Email: cspc@cspc.cn
News
News Center
Jul. 01
2024
CSPC Listed in 2023 Top 100 Chinese Chemical Pharmaceutical Enterprises
Jun. 28
VOLUNTARY ANNOUNCEMENT - ENLONSTOBART INJECTION OBTAINS CONDITIONAL MARKETING APPROVAL GRANTED BY NMPA
VOLUNTARY ANNOUNCEMENT - PALBOCICLIB TABLETS OBTAINS DRUG REGISTRATION APPROVAL
TRACE-III Clinical Study of CSPC Mingfule Presented at European Stroke Organisation Conference
Jinlitai® Made Its Debut in the 10th CSITF and Won the Top 10 Projects Award
Jun. 25
VOLUNTARY ANNOUNCEMENTFIRST mRNA-LNP-BASED CAR-T CELL INJECTION (SYS6020)OBTAINS CLINICAL TRIAL APPROVAL
Contact Us
Phone:
+86 311 8703 7015
Email:
cspc@cspc.cn
Products
Science
About Us
